Session Details
[Pj-052]Japanese Poster Session 052 Neuromuscular junction disease (MG:Treatment 2)
Thu. May 22, 2025 5:25 PM - 6:45 PM JST
Thu. May 22, 2025 8:25 AM - 9:45 AM UTC
Thu. May 22, 2025 8:25 AM - 9:45 AM UTC
ポスター会場(大阪国際会議場3F イベントホール)
Chair: Shunya Nakane(Department of Neurology, University of Toyama, Japan)
[Pj-052-2]A Study of Seven Cases of Molecularly Targeted Therapy for Generalized Myasthenia Gravis
Yukiyo Yoshimoto, Chizuko Sugita, Shoji Ogawa, Kensuke Kakiuchi, Yuichi Masuda, Shin Ota, Takafumi Hosokawa, Shigeki Arawaka (Division of Neurology, Department of Internal Medicine IV, Osaka Medical and Pharmaceutical University Hospital, Japan)
[Pj-052-3]Current status of the use of molecular-targeted drugs for myasthenia gravis at our hospital
Taichi Mitsui, Shuhei Takasawa, Risako Furuta, Hiroki Maesaka, Ryou Tanaka, Hiroaki Hirosawa, Noriyuki Matsuda, Ryoko Shibuya, Takamasa Nukui, Shunnya Nakane, Yuji Nakatsuji (Toyama University Hospital, Japan)
[Pj-052-4]Efficacy of Efgartigimod in Myasthenia Gravis
Riku Saito, Reiko Kawasaki, Takuya Sasaki, Yoshihumi Ogasawara, Kensuke Takahashi, Kagari Mano, Takahiro Nakayama, Ichiro Imafuku (Department of Neurology, Yokohama Rosai Hospital, Japan)
[Pj-052-1]Therapeutic strategy for ocular myasthenia gravis
Yuka Hayashi, Kazuki Fujita, Michiko Tsutsumiuchi, Yoshio Sakiyama (Department of Neurology, Jichi Medical University Saitama Medical Center, Japan)
[Pj-052-5]A study of the effect of Efgartigimod on Myasthenia Gravis over time
Tetsu Suzuki, Motoki Fujimaki, Takashi Hosaka, Ayako Shioya, Kiyotaka Nakamagoe, Yasushi Tomidokoro, Michihide Kajita, Kota Igari, Hajime Konishi, Naoki Sawahata, Mayuko Tanaka, Shinji Saiki (Department of Neurology, Faculty of Medicine, University of Tsukuba, Japan)
[Pj-052-6]Clinical characteristics of patients with MG treated with Efgartigimod in our hospital
Tatsuya Saito, Yuki Nakamura, Yuto Morishima, Atsuhiko Shindo, Hiroaki Murata, Takanori Hata, Kazumasa Shindo, Yuji Ueno (Department of Neurology, University of Yamanashi, Japan)